サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1629242

マイクロサテライト安定大腸癌市場：フェーズ別、投与経路別、製品別、国別、地域別 - 産業分析、市場規模、市場シェア、予測、2024年～2032年

Microsatellite Stable Colorectal Cancer Market, By Phase, By Route of Administration, By Products, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032

出版日
ページ情報
英文 303 Pages
納期
2～3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=143.57円
マイクロサテライト安定大腸癌市場：フェーズ別、投与経路別、製品別、国別、地域別 - 産業分析、市場規模、市場シェア、予測、2024年～2032年
出版日: 2024年12月04日
発行: AnalystView Market Insights
ページ情報: 英文 303 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

レポートハイライト

マイクロサテライト安定大腸癌市場 - 市場力学

がん罹患率の上昇

マイクロサテライト安定大腸癌市場は、新薬や治療法の迅速な承認によって大きく牽引されています。薬事承認は新規治療法の有効性と安全性を証明する重要なものであり、投資家、患者、ヘルスケア専門家の信頼を高めます。マイクロサテライト安定大腸癌による差し迫った医療需要への対応に加え、迅速な承認は新薬の入手を早め、患者が無用な遅延なく最先端の治療を受けられることを保証します。マイクロサテライト安定大腸癌の分野における絶え間ない技術革新のサイクルは、製薬企業やバイオテクノロジー企業が研究開発プロジェクトに投資することを奨励する規制条項によっても支えられています。新薬が承認されれば、マイクロサテライト安定大腸癌の様々な病期や分子的特徴に対応する様々な代替療法が提供され、市場環境が強化されます。

マイクロサテライト安定大腸癌市場 - 主要洞察

当社のリサーチアナリストが共有した分析によると、世界のマイクロサテライト安定大腸癌市場は、予測期間（2024年～2032年）に約5.00％のCAGRで毎年成長すると予測されています。

フェーズセグメンテーションに基づくと、2023年には早期製品（フェーズI）カテゴリーが最大の市場シェアを示すと予測されました。

投与経路のセグメンテーションに基づくと、静脈内投与が2023年の主要セグメントでした。

地域別では、北米が2023年に最大の収益源となりました。

マイクロサテライト安定大腸癌市場 - セグメンテーション分析：

世界のマイクロサテライト安定大腸癌市場は、フェーズ、投与経路、製品、地域に基づいてセグメント化されます。

投与経路に基づき、市場は経口、皮下、静脈内、筋肉内に分別されます。マイクロサテライト安定大腸癌の市場は、静脈内投与カテゴリーで大きく拡大しています。治療用化合物を直接血流に運び、より高い生物学的利用能と迅速な作用を保証する効率的なドラッグデリバリー方法に対するニーズの高まりが、この拡大の主な要因です。静脈内投与は正確な投与が可能で、強力な化学療法薬の悪影響を最小限に抑えることができるため、大腸癌の治療において非常に有益です。また、静脈内投与法の改善や、MSS大腸癌患者の静脈内投与用に特別に設計された新薬の創出も、このカテゴリーの上昇に拍車をかけています。

製品に基づき、市場は天然代謝物、低分子、モノクローナル抗体に分類されます。低分子は、重要な生物学的経路を標的とし、患者の予後を改善する能力があり、これがマイクロサテライト安定大腸癌市場での拡大の原動力となっています。低分子は細胞内に入りやすく、細胞内タンパク質と相互作用してがん細胞の増殖を効果的に阻止するため、MSS大腸癌に対する重要な治療選択肢になりつつあります。MSS大腸癌によく見られる遺伝子異常を正確に標的とする新しい低分子阻害剤の発見に集中した研究開発の継続が市場の成長を支えています。

マイクロサテライト安定大腸癌市場 - 地理的洞察

地理的には、マイクロサテライト安定大腸癌市場は北米、ラテンアメリカ、欧州、アジア太平洋、中東・アフリカの地域に広がっています。これらの地域は、ビジネスをもたらす国ごとにさらに分けられます。

北米におけるマイクロサテライト安定大腸癌市場は、特に米国とカナダにおける診断と治療方法の改善により、著しく拡大しています。がん研究への多額の投資、オーダーメイド医療の改善、大腸癌罹患率の上昇がこの開発の主な原因です。患者の転帰を向上させるため、北米の医療関係者は免疫療法や標的薬など、MSS大腸癌に特化した最先端の治療アプローチを用いるようになってきています。効率的なMSS大腸癌治療の必要性は、大腸癌検診や早期発見に対する意識の高まりにも後押しされています。

大腸癌の有病率の増加、標的治療薬の進歩、診断機器の画期的な進歩は、今後数年間、欧州のマイクロサテライト安定大腸癌市場の拡大を促進すると予想されます。大腸癌の発生は欧州全域で着実に増加しており、MSS亜型がこれらの症例の大きな割合を占めています。MSS大腸癌は、マイクロサテライト不安定性（MSI-H）の症例ではしばしば奏功する免疫療法に耐性を示すサブタイプであり、この症例数の増加により、MSS大腸癌に特化した革新的な治療戦略の必要性が浮き彫りになっています。加えて、最先端の診断技術の採用は、早期発見と高水準のがん治療に重点を置く欧州のヘルスケアシステムによって促進されています。

マイクロサテライト安定大腸癌市場 - 競合情勢：

Eli Lilly and Company、Sanofi、Bayer AG、Merck Sharp &Dohme Corp.、Bristol Myers Squibb、Regeneron Pharmaceuticals, Inc.など、標的治療、免疫療法、新規治療法の開発に取り組む主要競合企業の存在が、マイクロサテライト安定（MSS）大腸癌市場の競合環境を定義しています。著名な製薬企業やバイオテクノロジー企業は、従来の免疫療法では奏効しないことが多いMSS大腸癌特有の分子特性をターゲットとした新たな治療選択肢を生み出すための研究開発に資金を費やしています。臨床研究を迅速化し、新規治療を市場に提供するため、企業は研究機関と積極的に提携しています。

目次

第1章 マイクロサテライト安定大腸癌の市場概要

  • 調査範囲
  • 市場推定年

第2章 エグゼクティブサマリー

  • 市場内訳
  • 競合考察

第3章 マイクロサテライト安定大腸癌の主要市場動向

  • 市場促進要因
  • 市場抑制要因
  • 市場機会
  • 市場の将来動向

第4章 マイクロサテライト安定大腸癌の産業調査

  • PEST分析
  • ポーターのファイブフォース分析
  • 成長見通しマッピング
  • 規制枠組み分析

第5章 マイクロサテライト安定大腸癌市場：COVID-19の影響分析

  • COVID-19以前の影響分析
  • COVID-19以後の影響分析

第6章 マイクロサテライト安定大腸癌市場情勢

  • マイクロサテライト安定大腸癌市場シェア分析、2023年
  • 内訳データ：主要メーカー別
    • 既存企業の分析
    • 新興企業の分析

第7章 マイクロサテライト安定大腸癌市場：フェーズ別

  • 概要
    • セグメントシェア分析：フェーズ別
    • 初期段階の製品（フェーズI）
    • 中期段階の製品（フェーズII）
    • 前臨床・発見段階

第8章 マイクロサテライト安定大腸癌市場：投与経路別

  • 概要
    • セグメントシェア分析：投与経路別
    • 経口
    • 皮下
    • 静脈内
    • 筋肉内

第9章 マイクロサテライト安定大腸癌市場：製品別

  • 概要
    • 製品別セグメントシェア分析
    • 天然代謝物
    • 小分子
    • モノクローナル抗体

第10章 マイクロサテライト安定大腸癌市場：地域別

  • イントロダクション
  • 北米
    • 概要
    • 北米の主要メーカー
    • 米国
    • カナダ
  • 欧州
    • 概要
    • 欧州の主要メーカー
    • ドイツ
    • フランス
    • イタリア
    • スペイン
    • 英国
    • ロシア
    • オランダ
    • スウェーデン
    • ポーランド
    • その他
  • アジア太平洋（APAC）
    • 概要
    • アジア太平洋の主要メーカー
    • インド
    • 中国
    • 韓国
    • 日本
    • オーストラリア
    • タイ
    • インドネシア
    • フィリピン
    • その他
  • ラテンアメリカ
    • 概要
    • ラテンアメリカの主要メーカー
    • ブラジル
    • メキシコ
    • アルゼンチン
    • コロンビア
    • その他
  • 中東・アフリカ
    • 概要
    • 中東・アフリカの主要メーカー
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • トルコ
    • アルジェリア
    • エジプト
    • その他

第11章 主要ベンダー分析 - マイクロサテライト安定大腸癌業界

  • 競合ダッシュボード
  • 企業プロファイル
    • Eli Lilly and Company
    • Sanofi
    • Bayer AG
    • Merck Sharp & Dohme Corp.
    • Bristol Myers Squibb
    • Regeneron Pharmaceuticals, Inc.
    • Genentech, Inc.
    • Ipsen Biopharmaceuticals, Inc.
    • Pfizer Inc.
    • Taiho Pharmaceutical（Otsuka Pharmaceutical Co., Ltd.）
    • Novartis AG
    • Teva Pharmaceutical Industries Ltd.
    • その他

第12章 アナリストの全方位展望

目次
Product Code: ANV4506

REPORT HIGHLIGHT

Microsatellite stable colorectal cancer (MSS) is a subtype of colorectal cancer (CRC) that is distinguished by genomic stability in small repeating DNA sequences called microsatellite regions. In contrast to microsatellite instability (MSI), which occurs when these areas display aberrant lengths as a result of impairments in DNA mismatch repair, microsatellite stable colorectal cancers preserve the integrity of these regions. The majority of colorectal cancer cases are microsatellite stable colorectal cancer, which usually develops by other mechanisms, such as chromosomal instability (CIN) or CpG island methylator phenotype (CIMP), as opposed to DNA mismatch repair deficiencies. The demand for focused treatments and diagnostics has increased due to the rising incidence of colorectal cancer worldwide, particularly as a sizable portion of cases are microsatellite stable colorectal cancer. Additionally, early detection-which is essential for successful treatment-has been made possible by increased awareness and screening initiatives for colorectal cancer, which has fueled market expansion. Innovation in this industry has been further spurred by pharmaceutical companies' increased investment in R&D as well as growing interest in customized treatment.

Microsatellite Stable Colorectal Cancer Market- Market Dynamics

Rising Incidence of Cancer

The market for microsatellite stable colorectal cancer is driven in large part by prompt regulatory approvals of novel medications and treatments. The regulatory approval is an important validation of the efficacy and safety of novel therapies, boosting investor, patient, and healthcare professional trust. In addition to addressing the pressing medical demands caused by microsatellite stable colorectal cancer, rapid approvals speed up the availability of new medicines and guarantee that patients can receive state-of-the-art care without needless delays. A constant cycle of innovation in the field of microsatellite stable colorectal cancer is also supported by regulatory provisions that encourage pharmaceutical and biotechnology businesses to invest in R&D projects. As new medications are approved, they enhance the market environment by providing a range of therapy alternatives that address the different stages and molecular characteristics of microsatellite stable colorectal cancer.

Microsatellite Stable Colorectal Cancer Market- Key Insights

As per the analysis shared by our research analyst, the global Microsatellite Stable Colorectal Cancer Market is estimated to grow annually at a CAGR of around 5.00% over the forecast period (2024-2032)

Based on phase segmentation, early-stage products (phase I) category was predicted to show maximum market share in the year 2023

Based on route of administration segmentation, the intravenous was the leading segment in 2023

On the basis of region, North America was the leading revenue generator in 2023

Microsatellite Stable Colorectal Cancer Market- Segmentation Analysis:

The Global Microsatellite Stable Colorectal Cancer Market is segmented on the basis of Phase, Route of Administration, Products, and Region.

Based on the route of administration, the market is segregated into Oral, Subcutaneous, Intravenous, and Intramuscular. The market for microsatellite stable colorectal cancer is expanding significantly in the intravenous category. The growing need for efficient drug delivery methods that can carry therapeutic compounds straight into the bloodstream, guaranteeing greater bioavailability and quicker action, is a major factor in this expansion. Because it enables precise dosing and aids in minimizing the negative effects of powerful chemotherapy medications, intravenous administration is very beneficial in the treatment of colorectal cancer. The rise of this category has also been fueled by improvements in IV administration methods and the creation of new medications designed especially for IV usage in patients with MSS colorectal cancer.

Based on product, the market is categorized into Natural metabolites, Small molecules, and Monoclonal antibodies. Small molecule's ability to target important biological pathways and enhance patient outcomes is what is driving their expansion in the microsatellite stable colorectal cancer market. Since small molecules may readily enter cells and interact with intracellular proteins to effectively block the proliferation of cancer cells, they are becoming a significant therapeutic option for MSS colorectal cancer. Continued research and development efforts, which concentrate on finding new small-molecule inhibitors that precisely target genetic abnormalities common in MSS colorectal cancer, are supporting the market's growth.

Microsatellite Stable Colorectal Cancer Market- Geographical Insights

Geographically, the Microsatellite Stable Colorectal Cancer Market is widespread in the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business.

The market for microsatellite stable colorectal cancer in North America is expanding significantly due to improvements in diagnosis and treatment methods, especially in the US and Canada. Significant investments in cancer research, improvements in customized care, and rising incidence of colorectal cancer are some of the main causes of this development. To enhance patient outcomes, medical professionals in North America are increasingly using cutting-edge therapeutic approaches designed specifically for MSS colorectal cancer, such as immunotherapy and targeted medicines. The need for efficient MSS colorectal cancer treatments is also being driven by growing awareness of colorectal cancer screening and early detection initiatives.

The growing prevalence of colorectal cancer, advances in targeted therapeutics, and breakthroughs in diagnostic equipment are expected to propel the European microsatellite stable colorectal cancer market's expansion in the next years. Colorectal cancer occurrences have been steadily increasing throughout Europe, and MSS subtypes account for a significant share of these cases. The need for innovative treatment strategies specifically designed for MSS colorectal cancer, a subtype that frequently shows resistance to immunotherapies that are frequently successful in cases of microsatellite instability (MSI-H), is highlighted by this rise in cases. Additionally, the adoption of cutting-edge diagnostic technology is facilitated by the European healthcare system, which places a strong focus on early identification and high standards for cancer care.

Microsatellite Stable Colorectal Cancer Market- Competitive Landscape:

The existence of major competitors such as Eli Lilly and Company, Sanofi, Bayer AG, Merck Sharp & Dohme Corp., Bristol Myers Squibb, Regeneron Pharmaceuticals, Inc., and others committed to developing targeted treatments, immunotherapies, and novel treatment modalities defines the competitive environment of the Microsatellite Stable (MSS) Colorectal Cancer Market. Prominent pharmaceutical and biotechnology companies are spending money on research and development to create new therapeutic options that target the unique molecular characteristics of MSS colorectal cancer, which frequently responds less well to conventional immunotherapy techniques. In an effort to speed up clinical studies and provide novel treatments to the market, businesses are aggressively partnering with research institutions.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL MICROSATELLITE STABLE COLORECTAL CANCER MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • Eli Lilly and Company
  • Sanofi
  • Bayer AG
  • Merck Sharp & Dohme Corp.
  • Bristol Myers Squibb
  • Regeneron Pharmaceuticals, Inc.
  • Genentech, Inc.
  • Ipsen Biopharmaceuticals, Inc.
  • Pfizer Inc.
  • Taiho Pharmaceutical (Otsuka Pharmaceutical Co., Ltd.)
  • Novartis AG
  • Teva Pharmaceutical Industries Ltd.
  • Others

GLOBAL MICROSATELLITE STABLE COLORECTAL CANCER MARKET, BY PHASE- MARKET ANALYSIS, 2019 - 2032

  • Early-stage products (Phase I)
  • Mid-stage products (Phase II)
  • Pre-clinical and Discovery stage

GLOBAL MICROSATELLITE STABLE COLORECTAL CANCER MARKET, BY ROUTE OF ADMINISTRATION- MARKET ANALYSIS, 2019 - 2032

  • Oral
  • Subcutaneous
  • Intravenous
  • Intramuscular

GLOBAL MICROSATELLITE STABLE COLORECTAL CANCER MARKET, BY PRODUCTS- MARKET ANALYSIS, 2019 - 2032

  • Natural metabolites
  • Small molecules
  • Monoclonal antibodies

GLOBAL MICROSATELLITE STABLE COLORECTAL CANCER MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Microsatellite Stable Colorectal Cancer Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Microsatellite Stable Colorectal Cancer Market Snippet by Phase
    • 2.1.2. Microsatellite Stable Colorectal Cancer Market Snippet by Route of Administration
    • 2.1.3. Microsatellite Stable Colorectal Cancer Market Snippet by Products
    • 2.1.4. Microsatellite Stable Colorectal Cancer Market Snippet by Country
    • 2.1.5. Microsatellite Stable Colorectal Cancer Market Snippet by Region
  • 2.2. Competitive Insights

3. Microsatellite Stable Colorectal Cancer Key Market Trends

  • 3.1. Microsatellite Stable Colorectal Cancer Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Microsatellite Stable Colorectal Cancer Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Microsatellite Stable Colorectal Cancer Market Opportunities
  • 3.4. Microsatellite Stable Colorectal Cancer Market Future Trends

4. Microsatellite Stable Colorectal Cancer Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Microsatellite Stable Colorectal Cancer Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Microsatellite Stable Colorectal Cancer Market Landscape

  • 6.1. Microsatellite Stable Colorectal Cancer Market Share Analysis, 2023
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Microsatellite Stable Colorectal Cancer Market - By Phase

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Phase, 2023 & 2032 (%)
    • 7.1.2. Early-stage products (Phase I)
    • 7.1.3. Mid-stage products (Phase II)
    • 7.1.4. Pre-clinical and Discovery stage

8. Microsatellite Stable Colorectal Cancer Market - By Route of Administration

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Route of Administration, 2023 & 2032 (%)
    • 8.1.2. Oral
    • 8.1.3. Subcutaneous
    • 8.1.4. Intravenous
    • 8.1.5. Intramuscular

9. Microsatellite Stable Colorectal Cancer Market - By Products

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Products, 2023 & 2032 (%)
    • 9.1.2. Natural metabolites
    • 9.1.3. Small molecules
    • 9.1.4. Monoclonal antibodies

10. Microsatellite Stable Colorectal Cancer Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Microsatellite Stable Colorectal Cancer Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Phase, 2019 - 2032 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By Products, 2019 - 2032 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Phase, 2019 - 2032 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By Products, 2019 - 2032 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Phase, 2019 - 2032 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By Products, 2019 - 2032 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Microsatellite Stable Colorectal Cancer Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Phase, 2019 - 2032 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By Products, 2019 - 2032 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Phase, 2019 - 2032 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By Products, 2019 - 2032 (US$ Million)
    • 10.3.8. France
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.8.3. France Market Size and Forecast, By Phase, 2019 - 2032 (US$ Million)
      • 10.3.8.4. France Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 10.3.8.5. France Market Size and Forecast, By Products, 2019 - 2032 (US$ Million)
    • 10.3.9. Italy
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.9.3. Italy Market Size and Forecast, By Phase, 2019 - 2032 (US$ Million)
      • 10.3.9.4. Italy Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 10.3.9.5. Italy Market Size and Forecast, By Products, 2019 - 2032 (US$ Million)
    • 10.3.10. Spain
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.10.3. United Kingdom Market Size and Forecast, By Phase, 2019 - 2032 (US$ Million)
      • 10.3.10.4. United Kingdom Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 10.3.10.5. United Kingdom Market Size and Forecast, By Products, 2019 - 2032 (US$ Million)
    • 10.3.11. United Kingdom
      • 10.3.11.1. Overview
      • 10.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.11.3. United Kingdom Market Size and Forecast, By Phase, 2019 - 2032 (US$ Million)
      • 10.3.11.4. United Kingdom Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 10.3.11.5. United Kingdom Market Size and Forecast, By Products, 2019 - 2032 (US$ Million)
    • 10.3.12. Russia
      • 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.12.2. Russia Market Size and Forecast, By Phase, 2019 - 2032 (US$ Million)
      • 10.3.12.3. Russia Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 10.3.12.4. Russia Market Size and Forecast, By Products, 2019 - 2032 (US$ Million)
    • 10.3.13. Netherlands
      • 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.13.2. Netherlands Market Size and Forecast, By Phase, 2019 - 2032 (US$ Million)
      • 10.3.13.3. Netherlands Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 10.3.13.4. Netherlands Market Size and Forecast, By Products, 2019 - 2032 (US$ Million)
    • 10.3.14. Sweden
      • 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.14.2. Sweden Market Size and Forecast, By Phase, 2019 - 2032 (US$ Million)
      • 10.3.14.3. Sweden Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 10.3.14.4. Sweden Market Size and Forecast, By Products, 2019 - 2032 (US$ Million)
    • 10.3.15. Poland
      • 10.3.15.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.15.2. Poland Market Size and Forecast, By Phase, 2019 - 2032 (US$ Million)
      • 10.3.15.3. Poland Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 10.3.15.4. Poland Market Size and Forecast, By Products, 2019 - 2032 (US$ Million)
    • 10.3.16. Rest of Europe
      • 10.3.16.1. Overview
      • 10.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.16.3. Rest of the Europe Market Size and Forecast, By Phase, 2019 - 2032 (US$ Million)
      • 10.3.16.4. Rest of the Europe Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 10.3.16.5. Rest of the Europe Market Size and Forecast, By Products, 2019 - 2032 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Microsatellite Stable Colorectal Cancer Key Manufacturers in Asia Pacific
    • 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.4.4. Asia Pacific Market Size and Forecast, By Phase, 2019 - 2032 (US$ Million)
    • 10.4.5. Asia Pacific Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
    • 10.4.6. Asia Pacific Market Size and Forecast, By Products, 2019 - 2032 (US$ Million)
    • 10.4.7. India
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.7.3. India Market Size and Forecast, By Phase, 2019 - 2032 (US$ Million)
      • 10.4.7.4. India Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 10.4.7.5. India Market Size and Forecast, By Products, 2019 - 2032 (US$ Million)
    • 10.4.8. China
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.8.3. China Market Size and Forecast, By Phase, 2019 - 2032 (US$ Million)
      • 10.4.8.4. China Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 10.4.8.5. China Market Size and Forecast, By Products, 2019 - 2032 (US$ Million)
    • 10.4.9. South Korea
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.9.3. South Korea Market Size and Forecast, By Phase, 2019 - 2032 (US$ Million)
      • 10.4.9.4. South Korea Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 10.4.9.5. South Korea Market Size and Forecast, By Products, 2019 - 2032 (US$ Million)
    • 10.4.10. Japan
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.10.3. Japan Market Size and Forecast, By Phase, 2019 - 2032 (US$ Million)
      • 10.4.10.4. Japan Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 10.4.10.5. Japan Market Size and Forecast, By Products, 2019 - 2032 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Phase, 2019 - 2032 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By Products, 2019 - 2032 (US$ Million)
    • 10.4.12. Thailand
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.12.3. Thailand Market Size and Forecast, By Phase, 2019 - 2032 (US$ Million)
      • 10.4.12.4. Thailand Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 10.4.12.5. Thailand Market Size and Forecast, By Products, 2019 - 2032 (US$ Million)
    • 10.4.13. Indonesia
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.13.3. Indonesia Market Size and Forecast, By Phase, 2019 - 2032 (US$ Million)
      • 10.4.13.4. Indonesia Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 10.4.13.5. Indonesia Market Size and Forecast, By Products, 2019 - 2032 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Phase, 2019 - 2032 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By Products, 2019 - 2032 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Phase, 2019 - 2032 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By Products, 2019 - 2032 (US$ Million)
  • 10.5. Latin America
    • 10.5.1. Overview
    • 10.5.2. Microsatellite Stable Colorectal Cancer Key Manufacturers in Latin America
    • 10.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.5.4. Latin America Market Size and Forecast, By Phase, 2019 - 2032 (US$ Million)
    • 10.5.5. Latin America Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
    • 10.5.6. Latin America Market Size and Forecast, By Products, 2019 - 2032 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Phase, 2019 - 2032 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By Products, 2019 - 2032 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Phase, 2019 - 2032 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By Products, 2019 - 2032 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Phase, 2019 - 2032 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By Products, 2019 - 2032 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Phase, 2019 - 2032 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By Products, 2019 - 2032 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Phase, 2019 - 2032 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By Products, 2019 - 2032 (US$ Million)
  • 10.6. Middle East and Africa
    • 10.6.1. Overview
    • 10.6.2. Microsatellite Stable Colorectal Cancer Key Manufacturers in Middle East and Africa
    • 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.6.4. Middle East and Africa Market Size and Forecast, By Phase, 2019 - 2032 (US$ Million)
    • 10.6.5. Middle East and Africa Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
    • 10.6.6. Middle East and Africa Market Size and Forecast, By Products, 2019 - 2032 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Phase, 2019 - 2032 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By Products, 2019 - 2032 (US$ Million)
    • 10.6.8. United Arab Emirates
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.8.3. United Arab Emirates Market Size and Forecast, By Phase, 2019 - 2032 (US$ Million)
      • 10.6.8.4. United Arab Emirates Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 10.6.8.5. United Arab Emirates Market Size and Forecast, By Products, 2019 - 2032 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Phase, 2019 - 2032 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By Products, 2019 - 2032 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Phase, 2019 - 2032 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By Products, 2019 - 2032 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Phase, 2019 - 2032 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By Products, 2019 - 2032 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Phase, 2019 - 2032 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By Products, 2019 - 2032 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Phase, 2019 - 2032 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By Products, 2019 - 2032 (US$ Million)

11. Key Vendor Analysis- Microsatellite Stable Colorectal Cancer Industry

  • 11.1. Competitive Dashboard
  • 11.2. Company Profiles
    • 11.2.1. Eli Lilly and Company
    • 11.2.2. Sanofi
    • 11.2.3. Bayer AG
    • 11.2.4. Merck Sharp & Dohme Corp.
    • 11.2.5. Bristol Myers Squibb
    • 11.2.6. Regeneron Pharmaceuticals, Inc.
    • 11.2.7. Genentech, Inc.
    • 11.2.8. Ipsen Biopharmaceuticals, Inc.
    • 11.2.9. Pfizer Inc.
    • 11.2.10. Taiho Pharmaceutical (Otsuka Pharmaceutical Co., Ltd.)
    • 11.2.11. Novartis AG
    • 11.2.12. Teva Pharmaceutical Industries Ltd.
    • 11.2.13. Others

12. 360 Degree Analyst View

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us